Legal Representation
Attorney
James Surber
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 15, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Jun 15, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Jun 15, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Mar 1, 2023 | CNFR | R | FINAL REFUSAL WRITTEN |
| Mar 1, 2023 | GNFR | O | FINAL REFUSAL E-MAILED |
| Mar 1, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Jan 12, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 11, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jan 11, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 13, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sep 13, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sep 13, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 21, 2022 | RFTP | Z | REMOVED FROM TEAS PLUS |
| Jul 21, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 21, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jul 21, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 14, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 11, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Dietary and nutritional supplements for the treatment and prevention of viral and bacterial infections, respiratory distress, inflammation, and autoimmunity diseases; Pharmaceutical preparations for the treatment and prevention of viral and bacterial infections, respiratory distress, inflammation, and autoimmunity diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The English translation of OLTRE in the mark is FURTHER.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICAL"
USPTO Documents
Loading USPTO documents...